US Bancorp
MYOV

US Bancorp’s Myovant Sciences Ltd. MYOV Stock Holding History

US Bancorp’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-168
Closed -$3K – 4325
2022
Q3 		$3K Buy
+168
New +$2.68K ﹤0.01% 3785
2022
Q1 		– Sell
-69
Closed -$1K – 4265
2021
Q4 		$1K Sell
69
-324
-82% -$6.18K ﹤0.01% 4066
2021
Q3 		$9K Sell
393
-43
-10% -$944 ﹤0.01% 3504
2021
Q2 		$10K Buy
436
+43
+11% +$905 ﹤0.01% 3412
2021
Q1 		$8K Hold
393
– – ﹤0.01% 3389
2020
Q4 		$11K Sell
393
-1,607
-80% -$31.3K ﹤0.01% 3161
2020
Q3 		$28K Hold
2,000
– – ﹤0.01% 2664
2020
Q2 		$41K Buy
+2,000
New +$27.2K ﹤0.01% 2508

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

US Bancorp's MYOV Position: Q4 2022 in Review

US Bancorp sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 168 shares — an estimated $3K sold.

US Bancorp first reported a position in MYOV in Q2 2020 and held it in 8 quarters. The position peaked at $41K in Q2 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • US Bancorp reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 168 Myovant Sciences Ltd. shares in Q4 2022, an estimated $3K.
  • US Bancorp first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 8 quarters.
  • US Bancorp's Myovant Sciences Ltd. position peaked at $41K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.